Clinical Trial: Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: COVID-19
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Multicenter, Randomized, Double-blind, Placebo- Controlled, Parallel Group Study to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects
Brief Summary:
This is a first in human clinical study to evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of RQ-01.Adult patients who have tested positive for SARS-CoV-2 virus, have mild symptom(s) of COVID-19 disease, and who are at low risk for developing moderate or severe COVID-19 disease are welcome to participate.The main questions this study aims to answer are:What is the safety profile of RQ-01?What is the reduction in SARS-CoV-2 ribonucleic acid (RNA) shedding after administration of RQ-01?How…
Read more